Apolipoprotein profiles in subjects with and without peripheral artery disease

Vascular Medicine (United Kingdom)

Volumn 18, Issue 3, 2013, Pages 129-135

  Gardner, Andrew W ^a,b   Alaupovic, Petar ^c   Parker, Donald E ^d   Montgomery, Polly S ^d   Roof, Ashley ^d   Casanegra, Ana I ^e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

apolipoproteins; intermittent claudication; lipids; peripheral artery disease; statins

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR RISK; DRUG EFFICACY; EXERCISE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREADMILL ERGOMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84878375211     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X13489768     Document Type: Article

References (31)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006 ; 113: e463 - e654
2. Brass EP, Hiatt WR. Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies. Vasc Med. 2006 ; 11: 141-145
3. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992 ; 326: 381-386
4. Dormandy J, Heeck L, Vig S. The natural history of claudication: Risk to life and limb. Semin Vasc Surg. 1999 ; 12: 123-137
5. Muluk SC, Muluk VS, Kelley ME, et al. Outcome events in patients with claudication: A 15-year study in 2777 patients. J Vasc Surg. 2001 ; 33: 251-257
6. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: A review. J Clin Epidemiol. 1992 ; 45: 529-542
7. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 ; 45: S5-67
8. Gardner AW, Skinner JS, Cantwell BW, et al. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991 ; 23: 402-408
9. Hiatt WR, Nawaz D, Regensteiner JG, et al. The evaluation of exercise performance in patients with peripheral vascular disease. J Cardiopulm Rehabil. 1988 ; 12: 525-532
10. Gardner AW, Montgomery PS. The effect of metabolic syndrome components on exercise performance in patients with intermittent claudication. J Vasc Surg. 2008 ; 47: 1251-1258
11. Afaq A, Montgomery PS, Scott KJ, et al. The effect of hypercholestrolemia on calf muscle hemoglobin oxygen saturation in patients with intermittent claudication. Angiology. 2008 ; 59: 534-541
12. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004 ; 364: 937-952
13. Simonsson M, Schmidt C, Sigurdadottir V, et al. Life style habits such as alcohol consumption and physical activity in relation to serum apoB / apoA-I ratio amongst 64-year-old women with varying degrees of glucose tolerance. J Intern Med. 2007 ; 262: 537-544
14. Holme I, Hostmark AT, Anderssen SA. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study. J Intern Med. 2007 ; 262: 235-243
15. Gardner AW, Parker DE, Montgomery PS, et al. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: A randomized controlled trial. Circulation. 2011 ; 123: 491-498
16. Gardner AW, Montgomery PS, Scott KJ, et al. Patterns of ambulatory activity in subjects with and without intermittent claudication. J Vasc Surg. 2007 ; 46: 1208-1214
17. McConathy WJ, Greenhalgh RM, Alaupovic P, et al. Plasma lipid and apolipoprotein profiles of women with two types of peripheral arterial disease. Atherosclerosis. 1984 ; 50: 295-306
18. McConathy WJ, Alaupovic P, Woolcock N, et al. Lipids and apolipoprotein profiles in men with aneurysmal and stenosing aorto-iliac atherosclerosis. Eur J Vasc Surg. 1989 ; 3: 511-514
19. McDermott MM, Guralnik JM, Greenland P, et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation. 2003 ; 107: 757-761
20. Hiatt WR, Marshall JA, Baxter J, et al. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol. 1990 ; 43: 597-606
21. Criqui MH, Denenberg JO, Bird CE, et al. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996 ; 1: 65-71
22. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982 ; 28: 1379-1388
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 ; 18: 499-502
24. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest. 1987 ; 47: 739-744
25. Gardner AW, Killewich LA, Katzel LI, et al. Relationship between free-living daily physical activity and peripheral circulation in patients with intermittent claudication. Angiology. 1999 ; 50: 289-297
26. Behre C, Bergstrom G, Schmidt C. Moderate physical activity is associated with lower ApoB/ApoA-I ratios independently of other risk factors in healthy, middle-aged men. Angiology. 2010 ; 61: 775-779
27. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 ; 285: 2486-2497
28. Gardner AW, Montgomery PS, Parker DE. Metabolic syndrome impairs physical function, health-related quality of life, and peripheral circulation in patients with intermittent claudication. J Vasc Surg. 2006 ; 43: 1191-1196
29. Schillinger M, Exner M, Mlekusch W, et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J. 2004 ; 25: 742-748
30. Mohler ER, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003 ; 108: 1481-1486
31. Nael R, Montgomery PS, Scott KJ, et al. Gender differences in the prevalence and management of metabolic syndrome and its components in patients with peripheral artery disease. Angiology. 2011 ; 62: 657-661